Spots Global Cancer Trial Database for Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
Official Title: A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib and Dexamethasone in Multiple Myeloma Patients
Study ID: NCT01002248
Conditions
Study Description
Brief Summary: This is a randomized Phase III study to evaluate the efficacy and safety of perifosine when added to the combination of bortezomib and dexamethasone in multiple myeloma patients who have relapsed on a prior bortezomib treatment regimen.
Detailed Description: A pre-planned interim analysis is expected to take place in Q1 of 2013.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, La Verne, California, United States
, San Francisco, California, United States
, San Pablo, California, United States
, Aurora, Colorado, United States
, Boulder, Colorado, United States
, Colorado Springs, Colorado, United States
, Denver, Colorado, United States
, Lakewood, Colorado, United States
, Littleton, Colorado, United States
, Longmont, Colorado, United States
, Parker, Colorado, United States
, Pueblo, Colorado, United States
, Thornton, Colorado, United States
, Niles, Illinois, United States
, Winfield, Illinois, United States
, Baltimore, Maryland, United States
, Columbia, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
, Morristown, New Jersey, United States
, Great Neck, New York, United States
, Fargo, North Dakota, United States
, Portland, Oregon, United States
, Tualatin, Oregon, United States
, Kingsport, Tennessee, United States
, Bedford, Texas, United States
, Dallas, Texas, United States
, Fort Worth, Texas, United States
, Kerrville, Texas, United States
, San Antonio, Texas, United States
, San Antonio, Texas, United States
, Tyler, Texas, United States
, Ogden, Utah, United States
, Christiansburg, Virginia, United States
, Roanoke, Virginia, United States
, Salem, Virginia, United States
, Seattle, Washington, United States
, Spokane, Washington, United States
, Vancouver, Washington, United States
, Milwaukee, Wisconsin, United States
, Winnipeg, Manitoba, Canada
, Montreal, Quebec, Canada
, Montreal, Quebec, Canada
, Quebec City, Quebec, Canada
, Brno, Czech Republic, Czechia
, Prague, Czech Republic, Czechia
, Dublin 24, , Ireland
Keryx / AOI Pharmaceuticals Investigative Site, Dublin 7, , Ireland
, Dublin 8, , Ireland
, Dublin 9, , Ireland
, Galway, , Ireland
, Limerick, , Ireland
, Sligo, , Ireland
, Tullamore, , Ireland
, Waterford, , Ireland
, Afula, , Israel
, Ashkelon, , Israel
, Beer Sheva, , Israel
, Haifa, , Israel
, Jerusalem, , Israel
, Jerusalem, , Israel
, Nahariya, , Israel
, Petah Tikva, , Israel
, Rehovot, , Israel
, Tel Aviv, , Israel
, Tel-Hashomer, , Israel
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Moscow, , Russian Federation
, Moscow, , Russian Federation
, Saint Petersburg, , Russian Federation
, Saint Petersburg, , Russian Federation
, Samara, , Russian Federation
, Kosice, Slovak Republic, Slovakia
, Badalona, , Spain
, Barcelona, , Spain
, Barcelona, , Spain
, Barcelona, , Spain
, La Laguna, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Pamplona, , Spain
, Valencia, , Spain
, Zaragoza, , Spain
Contact Details
Name: Paul Richardson, MD
Affiliation: Dana-Farber Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
